News
ICER identifies new crop of 'unsupported' drug price rises
Gilead Sciences, Johnson & Johnson, Novartis, Exelixis, and Pfizer have been taken to task by ICER for price increases without new clinical evidence.
Sales & Marketing
Sponsored
Health Trends 2025: Reimagining What's Possible
Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl
Digital
Deep Dive: AI 2024
In this issue, we delve into the transformative impact of AI on healthcare and pharma, featuring insights on key AI trends from the floor of Frontiers Health, the ongoing battle against drift, and
Sales & Marketing
Sponsored
Maintaining focus to prosper in a complex and rapidly evolvi...
Launching a product is always an intense, pivotal moment, but in a fast moving era of scientific advances and regulatory change, it has become an even more critical enterprise.
R&D
Targeting proteins to bring new medicines to patients with f...
In a new pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Dr Victoria Richon, CEO of Entact Bio, a company focused on the small molecule space, with its team of scientists,
R&D
Sponsored
Rare Disease Diagnostics: Advancing Orphan Drug Development ...
This white paper is free and can be downloaded and read at your convenience
R&D
Partner Content
Advance Best-In-Class Treatment Across CNS, Emergency Use Tr...
With nasal delivery systems offering faster absorption and non-invasive administration, they are becoming a cornerstone of modern therapeutics.
R&D
Partner Content
7th Treg-Directed Therapies Summit
Unravelling Treg Biology, Pioneering Best-in-Class Approaches & Demonstrating Clinical Efficacy to Advance Validated Therapeutic Options in Autoimmunity, Inflammation & Beyond
Category :
News
/
